Journal article
Authors list: Pfafenrot, C; Schneider, T; Müller, C; Hung, LH; Schreiner, S; Ziebuhr, J; Bindereif, A
Publication year: 2021
Pages: 12502-12516
Journal: Nucleic Acids Research
Volume number: 49
Issue number: 21
ISSN: 0305-1048
Open access status: Gold
DOI Link: https://doi.org/10.1093/nar/gkab1096
Publisher: Oxford University Press
Abstract:
Circular RNAs (circRNAs) are noncoding RNAs that exist in all eukaryotes investigated and are derived from back-splicing of certain pre-mRNA exons. Here, we report the application of artificial circRNAs designed to act as antisense-RNAs. We systematically tested a series of antisense-circRNAs targeted to the SARS-CoV-2 genome RNA, in particular its structurally conserved 5'-untranslated region. Functional assays with both reporter transfections as well as with SARS-CoV-2 infections revealed that specific segments of the SARS-CoV-2 5'-untranslated region can be efficiently accessed by specific antisense-circRNAs, resulting in up to 90% reduction of virus proliferation in cell culture, and with a durability of at least 48 h. Presenting the antisense sequence within a circRNA clearly proved more efficient than in the corresponding linear configuration and is superior to modified antisense oligonucleotides. The activity of the antisense-circRNA is surprisingly robust towards point mutations in the target sequence. This strategy opens up novel applications for designer circRNAs and promising therapeutic strategies in molecular medicine.
Citation Styles
Harvard Citation style: Pfafenrot, C., Schneider, T., Müller, C., Hung, L., Schreiner, S., Ziebuhr, J., et al. (2021) Inhibition of SARS-CoV-2 coronavirus proliferation by designer antisense-circRNAs, Nucleic Acids Research, 49(21), pp. 12502-12516. https://doi.org/10.1093/nar/gkab1096
APA Citation style: Pfafenrot, C., Schneider, T., Müller, C., Hung, L., Schreiner, S., Ziebuhr, J., & Bindereif, A. (2021). Inhibition of SARS-CoV-2 coronavirus proliferation by designer antisense-circRNAs. Nucleic Acids Research. 49(21), 12502-12516. https://doi.org/10.1093/nar/gkab1096